Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 09:06:56 16/07/2024 pm IST			After market 01:29:49 am
26.06 ^EUR	-1.25%		26.1	+0.18%

15/07	BAYER AG : UBS sticks Neutral	ZD
15/07	European companies cut jobs as economy sputters	RE

BAYER AG : Barclays reiterates its Neutral rating

January 08, 2024 at 07:25 pm IST

Initially Neutral on the company, Barclays's analyst Emily Field maintained his recommendation. The target price is unchanged at EUR 40.

Latest news about Bayer AG

BAYER AG : UBS sticks Neutral	15/07	ZD
European companies cut jobs as economy sputters	15/07	RE
European Midday Briefing : Stocks Extend Rally as U.S. Rate Cut Hopes Deepen	12/07	DJ
BAYER AG : Jefferies gives a Neutral rating	12/07	ZD
Cooling Inflation in Germany, US Boosts DAX Index	11/07	MT
Bayer: FDA Fast Track designation for Parkinson's treatment	11/07	CF
Bayer's Gene Therapy for Parkinson's Gets US Fast Track, UK Innovation Passport Designations	11/07	MT
Fast-track status for gene therapy boosts Bayer	11/07	DP
BASF announces planned closure of two weed killer sites in Germany	10/07	RE
BAYER AG : JP Morgan reaffirms its Neutral rating	10/07	ZD
European companies cut jobs as economy sputters	09/07	RE
BAYER AG : Gets a Neutral rating from Deutsche Bank	09/07	ZD
That's not so bad, is it?	08/07
Silver lining but no stable upturn - VCI maintains its forecast	08/07	RE
BAYER AG : Goldman Sachs reiterates its Neutral rating	08/07	ZD
Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	02/07	CI
Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	28/06	DP
Chemicals collective agreement: Bonus days for union members	27/06	DP
German chemical sector employers, union agree 6.85% pay hike over 20 months	27/06	RE
Chemicals collective bargaining agreement: extra day for trade unionists	27/06	DP
The same old winners	27/06
Bayer's pharmaceuticals division plans to cut further managerial jobs	27/06	RE
Bayer's Pharmaceuticals Unit to Cut More Managerial Jobs Amid Reorganization	27/06	MT
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia	27/06	RE
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...	26/06

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : As soft as anticipated

May 14, 2024 at 11:42 pm IST

Bayer AG: Not out of the woods yet

March 06, 2024 at 09:16 pm IST

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

26.38 EUR

Average target price

35.91 EUR

Spread / Average Target

+36.10%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-22.52%	28.29B
ELI LILLY AND COMPANY	+61.53%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.66%	359B
MERCK & CO., INC.	+15.06%	325B
ABBVIE INC.	+9.18%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.67%	177B
PFIZER, INC.	+2.47%	165B

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

BAYER AG : Barclays reiterates its Neutral rating

Latest news about Bayer AG

Chart Bayer AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Bayer AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals